Search research articles
Contact Us
Filters
Showing results (191-200 of 340) with videos related to
Page
of 34
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2012
Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study
Xia Pu, Yuanqing Ye, Margaret R Spitz, et al.
Cancer
|
March 11, 2008
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features
Mahitosh Mandal, Jeffery N Myers, Scott M Lippman, et al.
Elife
|
September 21, 2022
Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways
Pan Cheng, Xin Zhao, Lizabeth Katsnelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors
Robin L Jones, Edward S Kim, Pilar Nava-Parada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2002
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia
S Eva Singletary, Edward N Atkinson, Ashraful Hoque, et al.
Cancer
|
February 24, 2012
Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors
Woo-Young Kim, Ludmila Prudkin, Lei Feng, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 22, 2009
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients
Vikram D Kekatpure, Jay O Boyle, Xi Kathy Zhou, et al.
Journal of the National Cancer Institute
|
October 5, 2013
Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway
Dong Hoon Shin, Hyo-Jong Lee, Hye-Young Min, et al.
Molecular Cancer Therapeutics
|
February 14, 2016
Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience
Maria Schwaederle, Barbara A Parker, Richard B Schwab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2010
Phase II study of dasatinib in patients with advanced non-small-cell lung cancer
Faye M Johnson, B Nebiyou Bekele, Lei Feng, et al.
Page
of 34
Search research articles
Search
Showing results (191-200 of 340) with videos related to
Sort By:
Page
of 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2012
Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study
Xia Pu, Yuanqing Ye, Margaret R Spitz, et al.
Cancer
|
March 11, 2008
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features
Mahitosh Mandal, Jeffery N Myers, Scott M Lippman, et al.
Elife
|
September 21, 2022
Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways
Pan Cheng, Xin Zhao, Lizabeth Katsnelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2014
Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors
Robin L Jones, Edward S Kim, Pilar Nava-Parada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2002
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia
S Eva Singletary, Edward N Atkinson, Ashraful Hoque, et al.
Cancer
|
February 24, 2012
Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors
Woo-Young Kim, Ludmila Prudkin, Lei Feng, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 22, 2009
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients
Vikram D Kekatpure, Jay O Boyle, Xi Kathy Zhou, et al.
Journal of the National Cancer Institute
|
October 5, 2013
Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway
Dong Hoon Shin, Hyo-Jong Lee, Hye-Young Min, et al.
Molecular Cancer Therapeutics
|
February 14, 2016
Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience
Maria Schwaederle, Barbara A Parker, Richard B Schwab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2010
Phase II study of dasatinib in patients with advanced non-small-cell lung cancer
Faye M Johnson, B Nebiyou Bekele, Lei Feng, et al.
Page
of 34